Once Upon a Farm, PBC (OFRM)
Data as of , from SEC Form 4 filings.
Net insider selling (90d)Watch OFRM
See up to 3 months of OFRM. The 7-day demo opens the 1M and 3M ranges and puts OFRM on your watchlist.
Start 7-day demoLatest OFRM insider trades
About Once Upon a Farm, PBC (OFRM)
Once Upon a Farm, PBC files with the SEC under CIK 0001696556 and is classified as food and kindred products. It is grouped with Consumer Staples companies on this site. Its offering priced on 9 February 2026 and it trades on NASDAQ.
OFRM Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 6 | 3,837 | $67K |
| Other acquisition / disposition | 4 | 289,814 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
OFRM insider transactions (Form 4)
9824 Form 4 filings on record, the earliest from Feb 10, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Chris Folena - Officer | Open-market sale | Common Stock | 662 | $16.98 | $11K | |
| Lawrence Steven Waldman - Officer | Open-market sale | Common Stock | 1,102 | $16.98 | $19K | |
| Cassandra Nicole Curtis - Officer | Open-market sale | Common Stock | 68 | $16.98 | $1K | |
| Lawrence Steven Waldman - Officer | Open-market sale | Common Stock | 1,206 | $18.01 | $22K | |
| Chris Folena - Officer | Open-market sale | Common Stock | 724 | $18.01 | $13K | |
| Cassandra Nicole Curtis - Officer | Open-market sale | Common Stock | 75 | $18.01 | $1K | |
| Larry Peiros - Director | Other | Common Stock | 63,393 footnote F1 | $0.00 | - | |
| Larry Peiros - Director | Other | Common Stock | 63,393 footnote F1 | $0.00 | - | |
| Larry Peiros - Director | Other | Common Stock | 81,514 footnote F1 | $0.00 | - | |
| Larry Peiros - Director | Other | Common Stock | 81,514 footnote F1 | $0.00 | - | |
| ||||||
| Lawrence Steven Waldman - Officer | Grant or award | Common Stock | 68,027 | $0.00 | - | |
| Lawrence Steven Waldman - Officer | Grant or award | Common Stock | 12,285 | $0.00 | - | |
| Chris Folena - Officer | Grant or award | Common Stock | 7,371 | $0.00 | - | |
| Cassandra Nicole Curtis - Officer | Grant or award | Common Stock | 7,371 | $0.00 | - | |
| S2G Investments, LLC - 10% Owner | Other | Common Stock | 950,166 | $0.00 footnote F1 | - | |
| S2G Investments, LLC - 10% Owner | Other | Common Stock | 234,498 | $0.00 footnote F3 | - | |
| S2G Investments, LLC - 10% Owner | Other | Common Stock | 188,683 | $0.00 footnote F3 | - | |
| S2G Investments, LLC - 10% Owner | Other | Common Stock | 1,726,216 | $0.00 footnote F3 | - | |
| S2G Investments, LLC - 10% Owner | Other | Common Stock | 1,180,868 | $0.00 footnote F4 | - | |
| S2G Investments, LLC - 10% Owner | Other | Common Stock | 688,478 | $0.00 footnote F5 | - | |
| S2G Investments, LLC - 10% Owner | Other | Common Stock | 546,040 | $0.00 footnote F3 | - | |
| S2G Investments, LLC - 10% Owner | Other | Convertible Promissory Note for Series D Preferred Stock | 950,166 | $0.00 | - | |
| S2G Investments, LLC - 10% Owner | Other | Series A-1 Preferred Stock | 234,498 | $0.00 | - | |
| S2G Investments, LLC - 10% Owner | Other | Series A-2 Preferred Stock | 188,683 | $0.00 | - | |
| S2G Investments, LLC - 10% Owner | Other | Convertible Promissory Note for Series C-1 Preferred Stock | 688,478 | $0.00 | - | |
| S2G Investments, LLC - 10% Owner | Other | Convertible Promissory Note for Series C-2 Preferred Stock | 1,180,868 | $0.00 | - | |
| S2G Investments, LLC - 10% Owner | Other | Series B-1 Preferred Stock | 546,040 | $0.00 | - | |
| S2G Investments, LLC - 10% Owner | Other | Series B-2 Preferred Stock | 1,726,216 | $0.00 | - | |
| ||||||
| Brett J. Thomas | Other | Common Stock | 7,411,502 | - footnote F1 | - | |
| Brett J. Thomas | Other | Common Stock | 107,749 | - footnote F1 | - | |
| Brett J. Thomas | Other | Common Stock | 2,274,219 | - footnote F1 | - | |
| Brett J. Thomas | Grant or award | Common Stock | 6,112 | $0.00 | - | |
| Brett J. Thomas | Other | Series A-2 Preferred Stock | 107,749 | $0.00 | - | |
| Brett J. Thomas | Other | Series B-1 Preferred Stock | 4,804,965 | $0.00 | - | |
| Brett J. Thomas | Other | Series B-2 Preferred Stock | 914,243 | $0.00 | - | |
| Brett J. Thomas | Other | Series C-1 Preferred Stock | 874,954 | $0.00 | - | |
| Brett J. Thomas | Other | Series D Preferred Stock | 817,340 | $0.00 | - | |
| Brett J. Thomas | Other | Series D Preferred Stock | 2,274,219 | $0.00 | - | |
| ||||||
| Jared Noah Jacobs | Other | Common Stock | 7,411,502 | - footnote F1 | - | |
| Jared Noah Jacobs | Other | Common Stock | 107,749 | - footnote F1 | - | |
| Jared Noah Jacobs | Other | Common Stock | 2,274,219 | - footnote F1 | - | |
| Jared Noah Jacobs | Grant or award | Common Stock | 6,112 | $0.00 | - | |
| Jared Noah Jacobs | Other | Series A-2 Preferred Stock | 107,749 | $0.00 | - | |
| Jared Noah Jacobs | Other | Series B-1 Preferred Stock | 4,804,965 | $0.00 | - | |
| Jared Noah Jacobs | Other | Series B-2 Preferred Stock | 914,243 | $0.00 | - | |
| Jared Noah Jacobs | Other | Series C-1 Preferred Stock | 874,954 | $0.00 | - | |
| Jared Noah Jacobs | Other | Series D Preferred Stock | 817,340 | $0.00 | - | |
| Jared Noah Jacobs | Other | Series D Preferred Stock | 2,274,219 | $0.00 | - | |
| ||||||
| CAVU Venture Partners II, LP | Other | Common Stock | 7,411,502 | - footnote F1 | - | |
| CAVU Venture Partners II, LP | Other | Common Stock | 107,749 | - footnote F1 | - | |
| CAVU Venture Partners II, LP | Other | Common Stock | 2,274,219 | - footnote F1 | - | |
| CAVU Venture Partners II, LP | Other | Series A-2 Preferred Stock | 107,749 | $0.00 | - | |
| CAVU Venture Partners II, LP | Other | Series B-1 Preferred Stock | 4,804,965 | $0.00 | - | |
| CAVU Venture Partners II, LP | Other | Series B-2 Preferred Stock | 914,243 | $0.00 | - | |
| CAVU Venture Partners II, LP | Other | Series C-1 Preferred Stock | 874,954 | $0.00 | - | |
| CAVU Venture Partners II, LP | Other | Series D Preferred Stock | 817,340 | $0.00 | - | |
| CAVU Venture Partners II, LP | Other | Series D Preferred Stock | 2,274,219 | $0.00 | - | |
| ||||||
| Walter E. Robb IV | Grant or award | Common Stock | 134,303 | - footnote F1 | - | |
| Walter E. Robb IV | Grant or award | Common Stock | 6,112 | $0.00 | - | |
| Walter E. Robb IV | Open-market purchase | Common Stock | 5,555 | $18.00 | $100K | |
| Walter E. Robb IV | Derivative | Series B-1 Preferred Stock | 16,082 | $0.00 | - | |
| Walter E. Robb IV | Derivative | Series B-2 Preferred Stock | 101,354 | $0.00 | - | |
| Walter E. Robb IV | Derivative | Series C-1 Preferred Stock | 6,657 | $0.00 | - | |
| Walter E. Robb IV | Derivative | Series D Preferred Stock | 10,210 | $0.00 | - | |
| ||||||
| Larry Peiros | Grant or award | Common Stock | 81,514 | - footnote F1 | - | |
| Larry Peiros | Grant or award | Common Stock | 6,112 | $0.00 | - | |
| Larry Peiros | Derivative | Series C-1 Preferred Stock | 57,372 | $0.00 | - | |
| Larry Peiros | Derivative | Series D Preferred Stock | 24,142 | $0.00 | - | |
| ||||||
| John M. Foraker - Officer | Grant or award | Common Stock | 473,092 | - footnote F1 | - | |
| John M. Foraker - Officer | Grant or award | Common Stock | 69,445 | - footnote F2 | - | |
| John M. Foraker - Officer | Derivative | Series A-1 Preferred Stock | 59,092 | $0.00 | - | |
| John M. Foraker - Officer | Derivative | Series A-2 Preferred Stock | 133,294 | $0.00 | - | |
| John M. Foraker - Officer | Derivative | Series B-1 Preferred Stock | 96,118 | $0.00 | - | |
| John M. Foraker - Officer | Derivative | Series B-2 Preferred Stock | 103,037 | $0.00 | - | |
| John M. Foraker - Officer | Derivative | Series C-1 Preferred Stock | 57,372 | $0.00 | - | |
| John M. Foraker - Officer | Derivative | Series D Preferred Stock | 24,179 | $0.00 | - | |
| John M. Foraker - Officer | Grant or award | Employee Stock Options (right to buy) | 98,288 | $0.00 | - | |
| ||||||
| Cassandra Nicole Curtis - Officer | Grant or award | Common Stock | 6,077 | $0.00 | - | |
| Cassandra Nicole Curtis - Officer | Derivative | Stock Appreciation Rights | 37,400 | - footnote F2 | - | |
| Cassandra Nicole Curtis - Officer | Grant or award | Employee Stock Options (right to buy) | 8,601 | $0.00 | - | |
| ||||||
| Jennifer Anne Garner | Grant or award | Common Stock | 239,360 | - footnote F1 | - | |
| Jennifer Anne Garner | Grant or award | Common Stock | 146,683 | - footnote F1 | - | |
| Jennifer Anne Garner | Derivative | Series A-1 Preferred Stock | 58,718 | $0.00 | - | |
| Jennifer Anne Garner | Derivative | Series B-1 Preferred Stock | 160,259 | $0.00 | - | |
| Jennifer Anne Garner | Derivative | Series B-2 Preferred Stock | 20,383 | $0.00 | - | |
| Jennifer Anne Garner | Derivative | Series C-1 Preferred Stock | 95,632 | $0.00 | - | |
| Jennifer Anne Garner | Derivative | Series D Preferred Stock | 51,051 | $0.00 | - | |
| ||||||
| Lawrence Steven Waldman - Officer | Grant or award | Common Stock | 22,570 | $0.00 | - | |
| Lawrence Steven Waldman - Officer | Derivative | Stock Appreciation Rights | 93,500 | - footnote F2 | - | |
| Lawrence Steven Waldman - Officer | Grant or award | Employee Stock Options (right to buy) | 31,944 | $0.00 | - | |
| ||||||
| Megan Reimers Bent | Grant or award | Common Stock | 46,039 | - footnote F1 | - | |
| Megan Reimers Bent | Grant or award | Common Stock | 6,112 | $0.00 | - | |
| Megan Reimers Bent | Derivative | Series C-1 Preferred Stock | 16,493 | $0.00 | - | |
| Megan Reimers Bent | Derivative | Series C-2 Preferred Stock | 29,546 | $0.00 | - | |
| ||||||
| Dara Bazzano | Grant or award | Common Stock | 6,112 | $0.00 | - | |
| Chris Folena - Officer | Grant or award | Common Stock | 6,077 | $0.00 | - | |
| Chris Folena - Officer | Derivative | Stock Appreciation Rights | 37,400 | - footnote F2 | - | |
| Chris Folena - Officer | Grant or award | Employee Stock Options (right to buy) | 8,601 | $0.00 | - | |
| ||||||
Item 2.02, 9.01
Item 2.02, 9.01
Item 5.02
Item 1.01, 9.01
OFRM insider trading FAQ
What is the latest insider trade for OFRM?
Once Upon a Farm, PBC (OFRM) had 7 insider filings in the last 90 days, with the most recent on 2026-09-16. The full record for OFRM runs to 24 Form 4 filings, the earliest from 2026-02-10. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying OFRM stock?
No insider purchases of OFRM were filed in the last 90 days. 1 purchase is on record for this company.
How many insiders are selling OFRM stock?
6 insider sales of OFRM were filed in the last 90 days, totaling $67K.
Where can I see OFRM SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects OFRM Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Consumer Staples companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Chris Folena view on EDGAR
- - Lawrence Steven Waldman view on EDGAR
- - Cassandra Nicole Curtis view on EDGAR
- - Lawrence Steven Waldman view on EDGAR
- - Chris Folena view on EDGAR
- - Cassandra Nicole Curtis view on EDGAR
- - Larry Peiros view on EDGAR
- - Lawrence Steven Waldman view on EDGAR
- - Lawrence Steven Waldman view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Insider activity in Consumer Staples
- Where OFRM's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow OFRM with a 7-day demo
- OFRM on your watchlist
- Every OFRM Form 4 filing on record
- Up to 3 months of OFRM price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
